This Early-Stage Biotech Stock Is Up 400% — Should You Buy Now?

Avidity Biosciences Today RNA Avidity Biosciences $44.98 -0.51 (-1.12$4.82 ▼ $48.80 Price Target$54.83 Add to Watchlist Avidity Biosciences NASDAQ: RNA is a biopharmaceutical stock focusing on RNA therapeutics. The company's stock is up around 400% so far in 2024. However, even with this massive appreciation, Wall Street analysts still see a solid upside in the stock. Based on recent analyst changes, the average price target is $62, implying an upside of 39%. Get Sarepta Therapeutics alert ...